Challenging Cases in Colposcopy and Cervical Cancer Screening
This course best serves healthcare professionals who have an intermediate to advanced level of medical knowledge and are interested in improving clinical outcomes of lower genital tract disorders. This course incorporates challenging cases in colposcopy and cervical cancer screening to help participants better manage patients within the frameworks of recent national recommendations published by ASCCP and other professional organizations. Such recommendations include the ASCCP/ACS/ASCP Screening Guidelines for the Prevention and Early Detection of Cervical Cancer, the ASCCP Guidelines for the Management of Abnormal Screening Tests and Cancer Precursors, the ASCCP/SGO Interim Guidance on the Clinical Use of Primary HPV Testing for Cervical Cancer Screening, and the ASCCP/CAP Lower Anogenital Squamous Terminology (LAST). The challenging cases presented in this course will not only help participants understand how to use various guidelines in common clinical situations, but they will also explore acceptable management scenarios in situations for which the guidelines and algorithms may not apply. While these guidelines have been in clinical use for several years now, they are not without controversy. Faculty will explore some of the controversial aspects of these guidelines via lectures and interactive discussion. This postgraduate course will provide participants with a better understanding of the rationale for the recommendations and provide them with the opportunities to apply the guidelines in various common, and uncommon, specific cases and patient populations.
Upon completion of this live educational activity, participants should be able to:
- Apply an understanding of the epidemiology and natural history of HPV and cervical cancer precursors to the rational screening of women for cervical cancer using the current consensus guidelines and interim guidance for use of primary HPV testing for cervical cancer screening;
- Apply the basic and clinical science underlying the Updated Consensus Management Guidelines to the individualized management of abnormal screening tests and pre-invasive histologic lesions;
- Manage women from special populations (e.g., adolescent, postmenopausal, and pregnant women) with abnormal screening results and CIN/AIS; and
- Interpret biopsy results that use the LAST terminology LSIL/HSIL rather than CIN1, CIN2, CIN3.
Continuing Medical Education (CME)
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)TM
ASCCP designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As an accredited provider of CME credit, ASCCP has implemented a process to ensure that anyone who is in a position to affect the content of an educational activity has disclosed all relevant financial relationships with any commercial interest. Any conflicts of interest have been resolved by ASCCP prior to the activity.
The following person(s) disclosed no relevant financial relationships:
- Lisa Flowers, MD – Content Reviewer, Planner
- Colleen Stockdale, MD, MS – Content Reviewer, Planner
- Alan Waxman, MD, MPH – Author, Content Reviewer, Planner
- Christina Arnold – Staff
- Kerry Curtis – Staff
- Cari Price – Staff
- Alisha Yocum – Staff
- Liesel Robinson – ASCCP Consultant (Senior Event Planner)
- Rich Ryan – ASCCP Consultant (Exhibit/Sponsorship Sales)